Eli Lilly has announced a reduction in the price of its obesity treatment, Zepbound, to enhance affordability for U.S. patients. Starting immediately, patients with a prescription...
Eli Lilly has announced a significant reduction in the prices of its obesity treatment, Zepbound, aiming to increase accessibility for U.S. patients. As of March 2024,...
Mangoceuticals (MGRX) has announced a strategic partnership with pharmaceutical leaders Eli Lilly (LLY) and Novo Nordisk (NVO) to facilitate direct sales of their GLP-1 weight loss...
This week saw significant movements in the business landscape, highlighted by the acquisition of Plymouth Industrial REIT (NYSE: PLYM). Entities associated with Makarora Management and funds...
This week saw significant business activity as entities linked to Makarora Management and Ares Alternative Credit entered into an agreement to acquire all outstanding shares of...
Investment firms Makarora Management and Ares Alternative Credit have made headlines this week by finalizing an agreement to acquire all outstanding shares of Plymouth Industrial REIT...
Several significant business transactions have emerged this week, highlighting a range of industries from real estate to pharmaceuticals. Notably, entities associated with Makarora Management and Ares...
U.S. stocks experienced fluctuations on October 20, 2023, but ultimately rebounded as concerns about the stability of regional banks and credit risks loomed large. The S&P...
Eli Lilly (NYSE: LLY) has reported promising results from a late-stage trial of its drug, Omvoh (mirikizumab-mrkz), aimed at treating patients with moderately to severely active...
